We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+12.49%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.18B
AUM Growth
+$410M
Cap. Flow
+$230M
Cap. Flow %
10.53%
Top 10 Hldgs %
65.42%
Holding
52
New
13
Increased
11
Reduced
11
Closed
16

Top Buys

Rank Stock Value
1
BIVV
Bioverativ Inc. Common Stock
BIVV
+$246M
2
EW icon
Edwards Lifesciences
EW
+$117M
3
AET
Aetna Inc
AET
+$92.4M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$90.2M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$88.8M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$99.7M
2
QGENF
QIAGEN NV
QGENF
+$79.9M
3
DHR icon
Danaher
DHR
+$74.4M
4
INCY icon
Incyte
INCY
+$74.3M
5
ZBH icon
Zimmer Biomet
ZBH
+$69.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.1%
2 Financials 9.22%
3 Materials 1.56%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QGENF
51
DELISTED
QIAGEN NV
QGENF
– –
-2,850,000
Closed -$79.9M
WOOF
52
DELISTED
VCA Inc.
WOOF
– –
-1,000,000
Closed -$68.7M
1 2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q1 2017 Portfolio in Review

As of Q1 2017, HealthCor Management held 52 positions worth $2.18B, up 23% from $1.77B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

HealthCor Management deployed $230M of net new capital in Q1 2017, opening 13 new positions and adding to 11 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 5,000,000 shares worth $272M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 81% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Quest Diagnostics, an estimated $99.7M trimmed.

  • HealthCor Management's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 5,000,000 shares worth $272M.
  • HealthCor Management added most to Aetna Inc in Q1 2017, an estimated $92.4M increase.
  • HealthCor Management's biggest Q1 2017 reduction was Quest Diagnostics, cutting an estimated $99.7M.
  • HealthCor Management fully exited QIAGEN NV in Q1 2017, selling an estimated $79.9M.
  • HealthCor Management's ten largest holdings make up 65% of its $2.18B portfolio in Q1 2017.
  • HealthCor Management opened 13 new positions and closed 16 in Q1 2017.
  • HealthCor Management's portfolio value rose 23% quarter-over-quarter to $2.18B.

Based on HealthCor Management's 13F filing for Q1 2017, filed 15 May 2017.